Literature DB >> 22730441

Leptin signaling in adipose tissue: role in lipid accumulation and weight gain.

Prachi Singh1, Timothy E Peterson, Fatima H Sert-Kuniyoshi, Jason A Glenn, Diane E Davison, Abel Romero-Corral, Snigdha Pusalavidyasagar, Michael D Jensen, Virend K Somers.   

Abstract

RATIONALE: The link between obesity, hyperleptinemia, and development of cardiovascular disease is not completely understood. Increases in leptin have been shown to impair leptin signaling via caveolin-1-dependent mechanisms. However, the role of hyperleptinemia versus impaired leptin signaling in adipose tissue is not known.
OBJECTIVE: To determine the presence and significance of leptin-dependent increases in adipose tissue caveolin-1 expression in humans. METHODS AND
RESULTS: We designed a longitudinal study to investigate the effects of increases in leptin on adipose tissue caveolin-1 expression during weight gain in humans. Ten volunteers underwent 8 weeks of overfeeding, during which they gained an average weight of 4.1±1.4 kg, with leptin increases from 7±3.8 to 12±5.7 ng/mL. Weight gain also resulted in changes in adipose tissue caveolin-1 expression, which correlated with increases in leptin (rho=0.79, P=0.01). In cultured human white preadipocytes, leptin increased caveolin-1 expression, which in turn impaired leptin cellular signaling. Functionally, leptin decreased lipid accumulation in differentiating human white preadipocytes, which was prevented by caveolin-1 overexpression. Further, leptin decreased perilipin and fatty acid synthase expression, which play an important role in lipid storage and biogenesis.
CONCLUSIONS: In healthy humans, increases in leptin, as seen with modest weight gain, may increase caveolin-1 expression in adipose tissue. Increased caveolin-1 expression in turn impairs leptin signaling and attenuates leptin-dependent lowering of intracellular lipid accumulation. Our study suggests a leptin-dependent feedback mechanism that may be essential to facilitate adipocyte lipid storage during weight gain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730441      PMCID: PMC3482005          DOI: 10.1161/CIRCRESAHA.112.273656

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Leptin upregulates caveolin-1 expression: implications for development of atherosclerosis.

Authors:  Prachi Singh; Timothy E Peterson; Fatima H Sert-Kuniyoshi; Michael D Jensen; Virend K Somers
Journal:  Atherosclerosis       Date:  2010-10-16       Impact factor: 5.162

2.  Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity.

Authors:  May-Yun Wang; Lelio Orci; Mariella Ravazzola; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

Review 3.  Adipose tissue: the link between obesity and cardiovascular disease.

Authors:  Vanessa DeClercq; Carla Taylor; Peter Zahradka
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2008-09

Review 4.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

Review 5.  Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity.

Authors:  Roger H Unger; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2010-03-10       Impact factor: 12.015

6.  Leptin therapy in insulin-deficient type I diabetes.

Authors:  May-yun Wang; Lijun Chen; Gregory O Clark; Young Lee; Robert D Stevens; Olga R Ilkayeva; Brett R Wenner; James R Bain; Maureen J Charron; Christopher B Newgard; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 7.  Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis.

Authors:  R B Ceddia
Journal:  Int J Obes (Lond)       Date:  2005-10       Impact factor: 5.095

Review 8.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

9.  Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Camilo Silva; Fernando Rotellar; María J Gil; Javier A Cienfuegos; Javier Salvador; Gema Frühbeck
Journal:  Clin Endocrinol (Oxf)       Date:  2007-09-04       Impact factor: 3.478

10.  Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway.

Authors:  Lei Jiang; Qiong Wang; Yue Yu; Feng Zhao; Ping Huang; Rong Zeng; Robert Z Qi; Wenjun Li; Yong Liu
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more
  9 in total

Review 1.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

Review 2.  Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1.

Authors:  Rajamma Mathew
Journal:  World J Cardiol       Date:  2014-08-26

3.  Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype.

Authors:  Andrea Guennoun; Melissa Kazantzis; Remy Thomas; Martin Wabitsch; Daniel Tews; Konduru Seetharama Sastry; Mouaadh Abdelkarim; Vladimir Zilberfarb; Arthur Donny Strosberg; Lotfi Chouchane
Journal:  J Transl Med       Date:  2015-04-30       Impact factor: 5.531

4.  The concurrent validity between leptin, BMI and skin folds during pregnancy and the year after.

Authors:  C L van der Wijden; H A Delemarre-van der Waal; W van Mechelen; M N M van Poppel
Journal:  Nutr Diabetes       Date:  2013-09-09       Impact factor: 5.097

5.  Expression of Caveolin 1 is enhanced by DNA demethylation during adipocyte differentiation. status of insulin signaling.

Authors:  Sara Palacios-Ortega; Maider Varela-Guruceaga; Fermín Ignacio Milagro; José Alfredo Martínez; Carlos de Miguel
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

6.  Differential effects of leptin on adiponectin expression with weight gain versus obesity.

Authors:  P Singh; P Sharma; K R Sahakyan; D E Davison; F H Sert-Kuniyoshi; A Romero-Corral; J M Swain; M D Jensen; F Lopez-Jimenez; T Kara; V K Somers
Journal:  Int J Obes (Lond)       Date:  2015-09-16       Impact factor: 5.095

7.  Association between genetically determined leptin and blood lipids considering alcohol consumption: a Mendelian randomisation study.

Authors:  Luqi Shen; José F Cordero; Jia-Sheng Wang; Ye Shen; Shengxu Li; Lirong Liang; Zhiyong Zou; Changwei Li
Journal:  BMJ Open       Date:  2019-11-07       Impact factor: 2.692

Review 8.  Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function.

Authors:  Julia T Stadler; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

9.  Maternal and Fetal Lipid and Adipokine Profiles and Their Association with Obesity.

Authors:  Mario Solis-Paredes; Salvador Espino Y Sosa; Guadalupe Estrada-Gutierrez; Sonia Nava-Salazar; Veronica Ortega-Castillo; Mario Rodriguez-Bosch; Eyerahi Bravo-Flores; Aurora Espejel-Nuñez; Maricruz Tolentino-Dolores; Rubí Gaona-Estudillo; Nancy Martinez-Bautista; Otilia Perichart-Perera
Journal:  Int J Endocrinol       Date:  2016-04-12       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.